The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Open accessAbstract
Epithelial-to-Mesenchymal Transition (EMT) has been shown to be crucial in tumorigenesis where the EMT program enhances metastasis, chemoresistance and tumor stemness. Due to its emerging role as a pivotal driver of tumorigenesis, targeting EMT is of great therapeutic interest in counteracting metastasis and chemoresistance in cancer patients. The hallmark of EMT is the upregulation of N-cadherin followed by the downregulation of E-cadherin, and this process is regulated by a complex network of signaling pathways and transcription factors. In this review, we summarized the recent understanding of the roles of E- and N-cadherins in cancer invasion and metastasis as well as the crosstalk with other signaling pathways involved in EMT. We also highlighted a few natural compounds with potential anti-EMT property and outlined the future directions in the development of novel intervention in human cancer treatments. We have reviewed 287 published papers related to this topic and identified some of the challenges faced in translating the discovery work from bench to bedside.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
The JAK/STAT signaling pathway
Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.00963 · Cited by 1,858
EMT, the cytoskeleton, and cancer cell invasion
Yilmaz, M., & Christofori, G. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9169-0 · Cited by 1,788
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., & Srinivas, P. (1998) · Planta Medica · doi:10.1055/s-2006-957450 · Cited by 1,656
Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S., & Piccolo, S. (2013) · Cell · doi:10.1016/j.cell.2013.07.042 · Cited by 1,651
Wnt signal transduction pathways
Komiya, Y., & Habas, R. (2008) · Organogenesis · doi:10.4161/org.4.2.5851 · Cited by 1,528 · cited 1×
“In the absence of Wnt signals, the soluble cytoplasmic pool of β-catenin is recruited into the Axin/APC degradation complex, while the adhesion function is based on a cadherin-bound, stable pool at the membrane [141].”
BackgroundLoss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2938 · Cited by 1,522
The complex world of WNT receptor signalling
Niehrs, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3470 · Cited by 1,492
The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., & van Roy, F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00260-x · Cited by 1,394
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Ashkenazi, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc821 · Cited by 1,360
The cell-cell adhesion molecule E-cadherin
van Roy, F., & Berx, G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8281-1 · Cited by 1,325
CADHERINS: A MOLECULAR FAMILY IMPORTANT IN SELECTIVE CELL-CELL ADHESION
Takeichi, M. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.001321 · Cited by 1,306
Yap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
The SLUG zinc-finger protein represses E-cadherin in breast cancer.
Hajra, K. M., Chen, D. Y., & Fearon, E. R. (2002) · PubMed · Cited by 1,020
BIRCHMEIER, W., & BEHRENS, J. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90003-5 · Cited by 1,002
Links between metabolism and cancer
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 998
Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5
Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., & Ashkenazi, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80212-5 · Cited by 975
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
ZHENG, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.928 · Cited by 963
Luteolin, a flavonoid, as an anticancer agent: A review
Imran, M., Rauf, A., Abu-Izneid, T., Nadeem, M., Shariati, M. A., Khan, I. A., Imran, A., Orhan, I. E., Rizwan, M., Atif, M., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108612 · Cited by 931
Lei, Q.-Y., Zhang, H., Zhao, B., Zha, Z.-Y., Bai, F., Pei, X.-H., Zhao, S., Xiong, Y., & Guan, K.-L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01874-07 · Cited by 924
Hippo pathway regulation by cell morphology and stress fibers
Wada, K.-I., Itoga, K., Okano, T., Yonemura, S., & Sasaki, H. (2011) · Development · doi:10.1242/dev.070987 · Cited by 849
Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human Cancers
Hirohashi, S. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65575-7 · Cited by 839
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationSprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., & Walczak, H. (2000) · Immunity · doi:10.1016/s1074-7613(00)80211-3 · Cited by 794
Huber, A. H., & Weis, W. I. (2001) · Cell · doi:10.1016/s0092-8674(01)00330-0 · Cited by 777
Involvement of Members of the Cadherin Superfamily in Cancer
Berx, G., & van Roy, F. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003129 · Cited by 709
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components
Kim, N.-G., Koh, E., Chen, X., & Gumbiner, B. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103345108 · Cited by 698
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
Jolly, M. K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00155 · Cited by 693
Metabolism and bioavailability oftrans-resveratrol
Wenzel, E., & Somoza, V. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500010 · Cited by 676
Functional correlation between cell adhesive properties and some cell surface proteins.
Takeichi, M. (1977) · The Journal of cell biology · doi:10.1083/jcb.75.2.464 · Cited by 626
Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling
Heuberger, J., & Birchmeier, W. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002915 · Cited by 619
Mutations of the human E-cadherin (CDH1) gene
Berx, G., Becker, K.-F., Höfler, H., & van Roy, F. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:4<226::aid-humu2>3.0.co;2-d · Cited by 607
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor
Suyama, K., Shapiro, I., Guttman, M., & Hazan, R. B. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00150-2 · Cited by 515
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Self-citationTransforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition
Thuault, S., Valcourt, U., Petersen, M., Manfioletti, G., Heldin, C.-H., & Moustakas, A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512110 · Cited by 499
Tuli, R., Tuli, S., Nandi, S., Huang, X., Manner, P. A., Hozack, W. J., Danielson, K. G., Hall, D. J., & Tuan, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305312200 · Cited by 492
Twist1-Induced Invadopodia Formation Promotes Tumor Metastasis
Eckert, M. A., Lwin, T. M., Chang, A. T., Kim, J., Danis, E., Ohno-Machado, L., & Yang, J. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.036 · Cited by 476
Beyond E-cadherin: roles of other cadherin superfamily members in cancer
van Roy, F. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3647 · Cited by 475
Manach, C., & Donovan, J. L. (2004) · Free Radical Research · doi:10.1080/10715760410001727858 · Cited by 456
Yao, D., Dai, C., & Peng, S. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0568 · Cited by 455
Modulating F‐actin organization induces organ growth by affecting the Hippo pathway
Sansores‐Garcia, L., Bossuyt, W., Wada, K., Yonemura, S., Tao, C., Sasaki, H., & Halder, G. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.157 · Cited by 430
Gan, L., Yang, Y., Li, Q., Feng, Y., Liu, T., & Guo, W. (2018) · Biomarker Research · doi:10.1186/s40364-018-0122-2 · Cited by 426
Boye, K., & Mælandsmo, G. M. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090526 · Cited by 413
Khalil, N. M., Nascimento, T. C. F. D., Casa, D. M., Dalmolin, L. F., Mattos, A. C. D., Hoss, I., Romano, M. A., & Mainardes, R. M. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2012.06.024 · Cited by 413
Regulation of cell–cell adhesion by the cadherin–catenin complex
Nelson, W. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360149 · Cited by 412
Tumor suppressor gene E-cadherin and its role in normal and malignant cells
Pećina-Šlaus, N. (2003) · Cancer Cell International · doi:10.1186/1475-2867-3-17 · Cited by 394
Hepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of Snail
Grotegut, S., von Schweinitz, D., Christofori, G., & Lehembre, F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601213 · Cited by 363
Cadherins and Epithelial-to-Mesenchymal Transition
Gheldof, A., & Berx, G. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-394311-8.00014-5 · Cited by 361
Mrozik, K. M., Blaschuk, O. W., Cheong, C. M., Zannettino, A. C. W., & Vandyke, K. (2018) · BMC Cancer · doi:10.1186/s12885-018-4845-0 · Cited by 356
Loh, C.-Y., Arya, A., Naema, A. F., Wong, W. F., Sethi, G., & Looi, C. Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00048 · Cited by 348
Self-citationPece, S., & Gutkind, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006578200 · Cited by 345
Silvis, M. R., Kreger, B. T., Lien, W.-H., Klezovitch, O., Rudakova, G. M., Camargo, F. D., Lantz, D. M., Seykora, J. T., & Vasioukhin, V. (2011) · Science Signaling · doi:10.1126/scisignal.2001823 · Cited by 342
Tanaka, H., Kono, E., Tran, C. P., Miyazaki, H., Yamashiro, J., Shimomura, T., Fazli, L., Wada, R., Huang, J., Vessella, R. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2236 · Cited by 339
The Hippo-YAP signaling pathway and contact inhibition of growth
Gumbiner, B. M., & Kim, N.-G. (2014) · Journal of Cell Science · doi:10.1242/jcs.140103 · Cited by 339
Chemo‐preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review
Imran, M., Rauf, A., Shah, Z. A., Saeed, F., Imran, A., Arshad, M. U., Ahmad, B., Bawazeer, S., Atif, M., Peters, D. G., et al. (2019) · Phytotherapy Research · doi:10.1002/ptr.6227 · Cited by 339
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
Jia, D., Lu, M., Jung, K. H., Park, J. H., Yu, L., Onuchic, J. N., Kaipparettu, B. A., & Levine, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816391116 · Cited by 336
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B. (2017) · Clinical Science · doi:10.1042/cs20160935 · Cited by 332
Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
Mereles, D., & Hunstein, W. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095592 · Cited by 325
Shirakihara, T., Saitoh, M., & Miyazono, K. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-03-0249 · Cited by 320
Tao, J., Calvisi, D. F., Ranganathan, S., Cigliano, A., Zhou, L., Singh, S., Jiang, L., Fan, B., Terracciano, L., Armeanu–Ebinger, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.004 · Cited by 317
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol
Chimento, A., De Amicis, F., Sirianni, R., Sinicropi, M. S., Puoci, F., Casaburi, I., Saturnino, C., & Pezzi, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061381 · Cited by 310
Keeping in touch with contact inhibition of locomotion
Mayor, R., & Carmona-Fontaine, C. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.03.005 · Cited by 308
Xiong, H., Hong, J., Du, W., Lin, Y.-W., Ren, L.-L., Wang, Y.-C., Su, W.-Y., Wang, J.-L., Cui, Y., Wang, Z.-H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295964 · Cited by 307
Molecular architecture of adherens junctions
Nagafuchi, A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00257-x · Cited by 302
Xu, J., Liu, D., Niu, H., Zhu, G., Xu, Y., Ye, D., Li, J., & Zhang, Q. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0487-8 · Cited by 283
Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization
Paik, J.-H., Skoura, A., Chae, S.-S., Cowan, A. E., Han, D. K., Proia, R. L., & Hla, T. (2004) · Genes & Development · doi:10.1101/gad.1227804 · Cited by 278
Barbuti, A., & Chen, Z.-S. (2015) · Cancers · doi:10.3390/cancers7040897 · Cited by 269
E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium
Auersperg, N., Pan, J., Grove, B. D., Peterson, T., Fisher, J., Maines-Bandiera, S., Somasiri, A., & Roskelley, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6249 · Cited by 254
Fransvea, E., Angelotti, U., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22201 · Cited by 253
Giannelli, G., Bergamini, C., Fransvea, E., Sgarra, C., & Antonaci, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.055 · Cited by 252
Toden, S., Okugawa, Y., Jascur, T., Wodarz, D., Komarova, N. L., Buhrmann, C., Shakibaei, M., Boland, C. R., & Goel, A. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv006 · Cited by 248
Bioavailability challenges associated with development of anti-cancer phenolics
Gao, S., & Hu, M. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791384081 · Cited by 242
Advances in Nanotechnology-Based Delivery Systems for Curcumin
Sun, M., Su, X., Ding, B., He, X., Liu, X., Yu, A., Lou, H., & Zhai, G. (2012) · Nanomedicine · doi:10.2217/nnm.12.80 · Cited by 239
Soluble 80‐kd fragment of cell‐CAM 120/80 disrupts cell‐cell adhesion
Wheelock, M. J., Buck, C. A., Bechtol, K. B., & Damsky, C. H. (1987) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240340305 · Cited by 236
Shanmugam, M. K., Kannaiyan, R., & Sethi, G. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.523502 · Cited by 235
Self-citationAraki, K., Shimura, T., Suzuki, H., Tsutsumi, S., Wada, W., Yajima, T., Kobayahi, T., Kubo, N., & Kuwano, H. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.452 · Cited by 231
Shanmugam, M. K., Lee, J. H., Chai, E. Z. P., Kanchi, M. M., Kar, S., Arfuso, F., Dharmarajan, A., Kumar, A. P., Ramar, P. S., Looi, C. Y., et al. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.03.005 · Cited by 230
Self-citationSoluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface
Tang, M. K. S., Yue, P. Y. K., Ip, P. P., Huang, R.-L., Lai, H.-C., Cheung, A. N. Y., Tse, K. Y., Ngan, H. Y. S., & Wong, A. S. T. (2018) · Nature Communications · doi:10.1038/s41467-018-04695-7 · Cited by 225
Perrais, M., Chen, X., Perez-Moreno, M., & Gumbiner, B. M. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-04-0348 · Cited by 219
Ju, J., Hong, J., Zhou, J.-N., Pan, Z., Bose, M., Liao, J., Yang, G.-Y., Liu, Y. Y., Hou, Z., Lin, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1949 · Cited by 219
Hulit, J., Suyama, K., Chung, S., Keren, R., Agiostratidou, G., Shan, W., Dong, X., Williams, T. M., Lisanti, M. P., Knudsen, K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3401 · Cited by 218
Cadherins in development and cancer
Stemmler, M. P. (2008) · Molecular BioSystems · doi:10.1039/b719215k · Cited by 214
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Shanmugam, M. K., Warrier, S., Kumar, A. P., Sethi, G., & Arfuso, F. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666170713094319 · Cited by 213
Self-citationYoshida, K., Toden, S., Ravindranathan, P., Han, H., & Goel, A. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx065 · Cited by 208
Kim, J.-B., Islam, S., Kim, Y. J., Prudoff, R. S., Sass, K. M., Wheelock, M. J., & Johnson, K. R. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1193 · Cited by 207
Ji, Q., Liu, X., Han, Z., Zhou, L., Sui, H., Yan, L., Jiang, H., Ren, J., Cai, J., & Li, Q. (2015) · BMC Cancer · doi:10.1186/s12885-015-1119-y · Cited by 203
Liao, X., Siu, M. K. Y., Au, C. W. H., Wong, E. S. Y., Chan, H. Y., Ip, P. P. C., Ngan, H. Y. S., & Cheung, A. N. Y. (2009) · Carcinogenesis · doi:10.1093/carcin/bgn230 · Cited by 201
Luo, H., Rankin, G. O., Liu, L., Daddysman, M. K., Jiang, B.-H., & Chen, Y. C. (2009) · Nutrition and Cancer · doi:10.1080/01635580802666281 · Cited by 196
Li, X., Deng, W., Nail, C. D., Bailey, S. K., Kraus, M. H., Ruppert, J. M., & Lobo-Ruppert, S. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209077 · Cited by 193
Epigenetic versus genetic alterations in the inactivation of E-cadherin
Strathdee, G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00057-3 · Cited by 192
Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin
Mohanty, C., Das, M., & Sahoo, S. K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.724676 · Cited by 192
Targeting cancer stem cells by curcumin and clinical applications
Li, Y., & Zhang, T. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.012 · Cited by 189
Qi, J., Chen, N., Wang, J., & Siu, C.-H. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0186 · Cited by 189
Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
Lewis-Tuffin, L. J., Rodriguez, F., Giannini, C., Scheithauer, B., Necela, B. M., Sarkaria, J. N., & Anastasiadis, P. Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013665 · Cited by 188
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh, S. S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12261 · Cited by 179
Nanoscale architecture of cadherin-based cell adhesions
Bertocchi, C., Wang, Y., Ravasio, A., Hara, Y., Wu, Y., Sailov, T., Baird, M. A., Davidson, M. W., Zaidel-Bar, R., Toyama, Y., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3456 · Cited by 178
Jiao, D., Wang, J., Lu, W., Tang, X., Chen, J., Mou, H., & Chen, Q.-Y. (2016) · Molecular Therapy - Oncolytics · doi:10.1038/mto.2016.18 · Cited by 175
α-Catenin and Vinculin Cooperate to Promote High E-cadherin-based Adhesion Strength
Thomas, W. A., Boscher, C., Chu, Y.-S., Cuvelier, D., Martinez-Rico, C., Seddiki, R., Heysch, J., Ladoux, B., Thiery, J. P., Mege, R.-M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.403774 · Cited by 172
Sethi, G., Chatterjee, S., Rajendran, P., Li, F., Shanmugam, M. K., Wong, K. F., Kumar, A. P., Senapati, P., Behera, A. K., Hui, K. M., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-66 · Cited by 171
Self-citationLi, W., Ma, J., Ma, Q., Li, B., Han, L., Liu, J., Xu, Q., Duan, W., Yu, S., Wang, F., et al. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990251 · Cited by 171
Hesperidin: A promising anticancer agent from nature
Devi, K. P., Rajavel, T., Nabavi, S. F., Setzer, W. N., Ahmadi, A., Mansouri, K., & Nabavi, S. M. (2015) · Industrial Crops and Products · doi:10.1016/j.indcrop.2015.07.051 · Cited by 168
Jagged–Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype
Boareto, M., Jolly, M. K., Lu, M., Onuchic, J. N., Clementi, C., & Ben‐Jacob, E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416287112 · Cited by 165
Wang, H., Zhang, H., Tang, L., Chen, H., Wu, C., Zhao, M., Yang, Y., Chen, X., & Liu, G. (2013) · Toxicology · doi:10.1016/j.tox.2012.09.017 · Cited by 165
A Positive Role of Cadherin in Wnt/β-Catenin Signalling during Epithelial-Mesenchymal Transition
Howard, S., Deroo, T., Fujita, Y., & Itasaki, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023899 · Cited by 163
Williams, E. J., Williams, G. H., Gour, B. J., Blaschuk, O. W., & Doherty, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4007 · Cited by 162
Mechanoregulation and pathology of YAP/TAZ via Hippo and non‐Hippo mechanisms
Dobrokhotov, O., Samsonov, M., Sokabe, M., & Hirata, H. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0202-9 · Cited by 162
Neuropilins: expression and roles in the epithelium
Wild, J. R. L., Staton, C. A., Chapple, K. S., & Corfe, B. M. (2012) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2012.00810.x · Cited by 161
Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance
Ferlini, C., Raspaglio, G., Mozzetti, S., Distefano, M., Filippetti, F., Martinelli, E., Ferrandina, G., Gallo, D., Ranelletti, F. O., & Scambia, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.51 · Cited by 160
Mohan, C. D., Bharathkumar, H., Bulusu, K. C., Pandey, V., Rangappa, S., Fuchs, J. E., Shanmugam, M. K., Dai, X., Li, F., Deivasigamani, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601104 · Cited by 159
Self-citationEpithelial-to-Mesenchymal Transition of Murine Liver Tumor Cells Promotes Invasion†,‡
Ding, W., You, H., Dang, H. T., LeBlanc, F., Galicia, V. A., Lu, S. C.-L., Stiles, B. L., & Rountree, B. C. (2010) · Hepatology · doi:10.1002/hep.23748 · Cited by 158
Furukawa, K. T., Yamashita, K., Sakurai, N., & Ohno, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.032 · Cited by 158
Absence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic Cancer
Winter, J. M., Ting, A. H., Vilardell, F., Gallmeier, E., Baylin, S. B., Hruban, R. H., Kern, S. E., & Iacobuzio–Donahue, C. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0487 · Cited by 157
Zaidel‐Bar, R. (2013) · Journal of Cell Science · doi:10.1242/jcs.111559 · Cited by 156
Gli1 acts through Snail and E-cadherin to promote nuclear signaling by β-catenin
Li, X., Deng, W., Lobo-Ruppert, S. M., & Ruppert, J. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210241 · Cited by 155
Mukherjee, S., Mazumdar, M., Chakraborty, S., Manna, A., Saha, S., Khan, P., Bhattacharjee, P., Guha, D., Adhikary, A., Mukherjee, S., et al. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt506 · Cited by 155
YAP is a critical oncogene in human cholangiocarcinoma
Pei, T., Li, Y., Wang, J., Wang, H., Liang, Y., Shi, H., Sun, B., Yin, D., Sun, J., Song, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4043 · Cited by 154
WANG, M., Ren, D., Guo, W., Huang, S., Wang, Z., Li, Q., Du, H., Song, L., & Peng, X. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3270 · Cited by 154
Beyond a tumor suppressor: Soluble E ‐cadherin promotes the progression of cancer
Hu, Q., Kuang, J., Yang, Q., Bian, X., & Yu, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29982 · Cited by 154
Buhrmann, C., Shayan, P., Kraehe, P., Popper, B., Goel, A., & Shakibaei, M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.105 · Cited by 153
Evolution and diversity of cadherins and catenins
Gül, I. S., Hulpiau, P., Saeys, Y., & Roy, F. M. V. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.001 · Cited by 153
Chen, A., Beetham, H. G., Black, M. A., Priya, R., Telford, B. J., Guest, J., Wiggins, G. A. R., Godwin, T. D., Yap, A. S., & Guilford, P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-552 · Cited by 152
Haÿ, E., Laplantine, E., Geoffroy, V., Frain, M., Kohler, T., Müller, R., & Marie, P. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00349-08 · Cited by 150
Metastatic Progression of Prostate Cancer and E-Cadherin
Putzke, A. P., Ventura, A. P., Bailey, A. M., Akture, C., Opoku‐Ansah, J., Çeliktaş, M., Hwang, M. S., Darling, D. S., Coleman, I. M., Nelson, P. S., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.028 · Cited by 149
Rajendran, P., Li, F., Shanmugam, M. K., Vali, S., Abbasi, T., Kapoor, S., Ahn, K. S., Kumar, A. P., & Sethi, G. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22954 · Cited by 149
Self-citationJo, E., Park, S. J., Choi, Y. S., Jeon, W.-K., & Kim, B.-C. (2015) · Neoplasia · doi:10.1016/j.neo.2015.06.004 · Cited by 148
Subramaniam, A., Shanmugam, M. K., Ong, T. H., Li, F., Perumal, E., Chen, L., Vali, S., Abbasi, T., Kapoor, S., Ahn, K. S., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12302 · Cited by 147
Self-citationHollestelle, A., Peeters, J. K., Smid, M., Timmermans, M. A. M., Verhoog, L. C., Westenend, P. J., Heine, A. A. J., Chan, A. B., Sieuwerts, A. M., Wiemer, E. A. C., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2415-3 · Cited by 141
Reddy, P., Liu, L., Ren, C., Lindgren, P., Boman, K., Shen, Y., Lundin, E., Ottander, U., Rytinki, M. M., & Liu, K. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0342 · Cited by 140
Wang, X., Duan, X., Yang, G., Zhang, X., Deng, L., Zheng, H., Deng, C., Wen, J., Wang, N., Peng, C. Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018490 · Cited by 138
Thipe, V. C., Amiri, K. P., Bloebaum, P., Raphael, A. K., Khoobchandani, M., Katti, K. K., Jurisson, S. S., & Katti, K. V. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s204443 · Cited by 138
Liu, J., Chen, S., Lin, C., Tsai, S., & Liang, Y. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1261 · Cited by 137
Parisini, E., Higgins, J. M. G., Liu, J., Brenner, M. B., & Wang, J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.08.011 · Cited by 137
Miyamoto, Y., Sakane, F., & Hashimoto, K. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1005466 · Cited by 133
Cilibrasi, C., Riva, G., Romano, G., Cadamuro, M., Bazzoni, R., Butta, V., Paoletta, L., Dalprà, L., Strazzabosco, M., Lavitrano, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169854 · Cited by 132
Maher, M. T., Flozak, A. S., Stocker, A. M., Chenn, A., & Gottardi, C. J. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200811108 · Cited by 131
Alpha-Catenins Control Cardiomyocyte Proliferation by Regulating Yap Activity
Li, J., Gao, E., Vite, A., Yi, R., Gomez, L., Goossens, S., Roy, F. M. V., & Radice, G. L. (2014) · Circulation Research · doi:10.1161/circresaha.116.304472 · Cited by 131
Du, Y., Long, Q., Zhang, L., SHI, Y., LIU, X., Li, X., GUAN, B., TIAN, Y., Wang, X., Li, L., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3202 · Cited by 130
Wang, X., Mukhopadhyay, D., & Xu, X. (2006) · The FASEB Journal · doi:10.1096/fj.05-5504fje · Cited by 128
Seddiki, R., Narayana, G. H. N. S., Strale, P., Balcioglu, H. E., Peyret, G., Yao, M., Le, A. P., Lim, C. T., Yan, J., Ladoux, B., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-04-0231 · Cited by 127
Qi, J., Wang, J., Romanyuk, O., & Siu, C. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-10-0927 · Cited by 121
Li, Z., Liu, X., Wang, B., Nie, Y., Wen, J., Wang, Q., & Gu, C. (2016) · Nephrology · doi:10.1111/nep.12831 · Cited by 118
E-cadherin downregulation in cancer: fuel on the fire?
Guilford, P. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01461-6 · Cited by 117
E-Cadherin Couples Death Receptors to the Cytoskeleton to Regulate Apoptosis
Lu, M., Marsters, S. A., Ye, X., Luis, E., Gonzalez, L. C., & Ashkenazi, A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.029 · Cited by 117
Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin
Umerska, A. M., Gaucher, C., Oyarzun-Ampuero, F. A., Fries, I., Colin, F., Villamizar‐Sarmiento, M. G., Maincent, P., & Sapin‐Minet, A. (2018) · Antioxidants · doi:10.3390/antiox7040046 · Cited by 117
Zhao, Z., Cheng, X., Wang, Y., Han, R., Li, L., Xiang, T., He, L., Long, H., Zhu, B., & He, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095884 · Cited by 115
Pharmacological benefits of neferine - A comprehensive review
Shibu, M. A., Mariappan, R., Muthusamy, S., & Velmurugan, B. K. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.02.032 · Cited by 115
Chen, W., Lai, Y.-A., Lin, Y.-C., Ma, J.-W., Huang, L., Yang, N.-S., Ho, C., Kuo, S., & Way, T. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf404092f · Cited by 114
Honokiol: An anticancer lignan
Rauf, A., Patel, S. V., Imran, M., Maalik, A., Arshad, M. U., Saeed, F., Mabkhot, Y. N., Al–Showiman, S. S., Ahmad, N., & Elsharkawy, E. R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.054 · Cited by 114
Zang, M., Hu, L., Fan, Z., Wang, H., Zhu, Z., Cao, S., Wu, X., Li, J., Su, L., Li, C., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1151-6 · Cited by 113
Sun, X., LIU, X.-E., & Huang, D. (2013) · Oncology Reports · doi:10.3892/or.2013.2385 · Cited by 111
Yang, H., Wang, L., Zhao, J., Chen, Y., Lei, Z., Liu, X., Xia, W., Guo, L., & Zhang, H. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2014.12.015 · Cited by 109
Rosso, M., Majem, B., Devis, L., Lapyckyj, L., Besso, M. J., Llauradó, M., Abascal, M. F., Matos, M. L., Lanau, L., Castellví, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184439 · Cited by 109
The Role of Intrinsic Pathway in Apoptosis Activation and Progression in Peyronie’s Disease
Loreto, C., La Rocca, G., Anzalone, R., Caltabiano, R., Vespasiani, G., Castorina, S., Ralph, D. J., Cellek, S., Musumeci, G., Giunta, S., et al. (2014) · BioMed Research International · doi:10.1155/2014/616149 · Cited by 108 · cited 1×
“Several stimuli such as DNA damage, ischemia and oxidative stress lead to perturbation of mitochondrial membrane and release of cytochrome C into cytosol, where it initiates intrinsic apoptosis by inducing caspase activation [72,74].”
BackgroundSoluble E-cadherin: more than a symptom of disease
Grabowska, M. M. (2011) · Frontiers in bioscience · doi:10.2741/4031 · Cited by 106
Curcumin and Emodin Down-Regulate TGF-β Signaling Pathway in Human Cervical Cancer Cells
Pooja, T., & Karunagaran, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120045 · Cited by 104
Prognostic Significance of Twist and N-Cadherin Expression in NSCLC
Hui, L., Zhang, S., Dong, X.-J., Tian, D.-L., Cui, Z., & Qiu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062171 · Cited by 104
Shen, Y., Lin, C., Chi, W.-H., Wang, C.-Y., Hsieh, Y.-T., Wei, Y., & Chen, Y.-J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/590393 · Cited by 103
Hu, F., Tsai, L., Yu, C., Chen, P., Chou, M., & Yu, C. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200150 · Cited by 103
Dermani, F. K., Saidijam, M., Amini, R., Mahdavinezhad, A., Heydari, K., & Najafi, R. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25816 · Cited by 103
Avtanski, D. B., Nagalingam, A., Bonner, M. Y., Arbiser, J. L., Saxena, N. K., & Sharma, D. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.01.004 · Cited by 101
Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin
Zhou, Q., Yan, B., Hu, X., Li, X., Zhang, J., & Fang, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0191 · Cited by 101
Chu, Q., Ling, M.-T., Feng, H., Cheung, H. W., Tsao, S. W., Wang, X., & Wong, Y. C. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl054 · Cited by 100
Li, C., Xia, W., Lim, S., Hsu, J. L., Huo, L., Wu, Y., Li, L., Lai, C., Chang, S.-S., Hsu, Y.-H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1941 · Cited by 99
Chen, K., Chen, C.-Y., Lin, C.-J., Yang, T., Chen, T.-H., Wu, L.-C., & Wu, C. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.10.004 · Cited by 97
Gao, Q., Yuan, Y., Gan, H., & PENG, Q. (2015) · Oncology Letters · doi:10.3892/ol.2015.2988 · Cited by 95
Vergara, D., Valente, C. M., Tinelli, A., Siciliano, C., Lorusso, V., Acierno, R., Giovinazzo, G., Santino, A., Storelli, C., & Maffia, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.04.009 · Cited by 94
Roles of p38 MAPK and JNK in TGF-β1-induced Human Alveolar Epithelial to Mesenchymal Transition
Chen, H., Zhou, X., Shi, Y., & Yang, J. (2013) · Archives of Medical Research · doi:10.1016/j.arcmed.2013.01.004 · Cited by 91
Peluso, J. J., Pappalardo, A., & Trolice, M. P. (1996) · Endocrinology · doi:10.1210/endo.137.4.8625889 · Cited by 90
Li, C., Wang, Q., Shen, S., Wei, X., & Li, G. (2019) · Phytotherapy Research · doi:10.1002/ptr.6273 · Cited by 90
Al-Hujaily, E. M., Gaafar, A., Al-Sharif, I. S., Youssef, K. M., Manogaran, P. S., Al‐Otaibi, B., Al‐Hazzaa, A. A., Al‐Jammaz, I., Al‐Hussein, K., & Aboussekhra, A. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1089-3 · Cited by 88
Baribeau, S., Chaudhry, P., Parent, S., & Asselin, É. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086987 · Cited by 87
Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway
Woo, J. K., Choi, Y. K., Oh, S.-H., Jeong, J.-H., Choi, D.-H., Seo, H.-S., & Kim, C.-W. (2011) · Oncogene · doi:10.1038/onc.2011.410 · Cited by 86
Park, S. Y., Chae, S. Y., Park, J. O., Lee, K. J., & Park, G. (2016) · Oncology Reports · doi:10.3892/or.2016.4716 · Cited by 86
PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer
Lamprecht, S., Kaller, M., Schmidt, E. M., Blaj, C., Schiergens, T. S., Engel, J., Jung, A., Hermeking, H., Grünewald, T. G. P., Kirchner, T., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2572 · Cited by 86
Cadherin signaling: keeping cells in touch
Klezovitch, O., & Vasioukhin, V. I. (2015) · F1000Research · doi:10.12688/f1000research.6445.1 · Cited by 85
Li, Q., & Mattingly, R. R. (2008) · Neoplasia · doi:10.1593/neo.08968 · Cited by 84
Kachroo, P., Lee, M.-H., Zhang, L., Baratelli, F. E., Lee, G., Srivastava, M. K., Wang, G., Walser, T. C., Krysan, K., Sharma, S. P., et al. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-97 · Cited by 84
Howard, E. W., Ling, M., Chua, C. W., Cheung, H. W., Wang, X., & Wong, Y. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2074 · Cited by 83
Shen, T., Jiang, T., Long, M., Chen, J., Ren, D.-M., Wong, P. K., Chapman, E., Zhou, B., & Zhang, D. D. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6074 · Cited by 82
Chu, W., Song, X., Yang, X., Ma, L., Zhu, J., He, M., Wang, Z., & Wu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101931 · Cited by 82
Selvi, R. B., Swaminathan, A., Chatterjee, S., Shanmugam, M. K., Li, F., Ramakrishnan, G. B., Siveen, K. S., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6245 · Cited by 82
Self-citationLiang, S.-Q., Marti, T. M., Dorn, P., Froment, L., Hall, S., Berezowska, S., Kocher, G. J., Schmid, R. A., & Peng, R. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.195 · Cited by 81
Bahm, I., Barriga, E. H., Frolov, A., Théveneau, E., Frankel, P., & Mayor, R. (2017) · Development · doi:10.1242/dev.147926 · Cited by 79
From Notch signaling to fine-grained patterning: Modeling meets experiments
Shaya, O., & Sprinzak, D. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.07.007 · Cited by 76
Kumari, M., Ray, L., Purohit, M. P., Patnaik, S., Pant, A. B., Shukla, Y., Kumar, P., & Gupta, K. C. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.05.003 · Cited by 76
Hawkins, K., Mohamet, L., Ritson, S., Merry, C. L. R., & Ward, C. M. (2012) · Stem Cells · doi:10.1002/stem.1148 · Cited by 75
Zhang, L., Cheng, X. F., Gao, Y., Zhang, C., Bao, J., Guan, H., Yu, H., Lu, R., Xu, Q., & Sun, Y. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.006 · Cited by 75
Deng, G., Zeng, S., Ma, J., Zhang, Y., Qu, Y., Han, Y., Yin, L., Cai, C., Guo, C., & Shen, H. (2017) · Scientific Reports · doi:10.1038/srep41616 · Cited by 75
Park, K., & Gumbiner, B. M. (2010) · Development · doi:10.1242/dev.050096 · Cited by 73
Cited by
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
Pan, G., Liu, Y., Shang, L., Zhou, F., & Yang, S. (2021) · Cancer Communications · doi:10.1002/cac2.12138 · Cited by 362
Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., et al. (2021) · Cancers · doi:10.3390/cancers13081882 · Cited by 184
Self-citationTGF-β signaling networks in the tumor microenvironment
Chan, M. K.-K., Chung, J. Y.-F., Tang, P. C.-T., Chan, A. S.-W., Ho, J. Y.-Y., Lin, T. P.-T., Chen, J., Leung, K.-T., To, K.-F., Lan, H.-Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215925 · Cited by 90
Metadata
- Authors
- Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-09-20
- Volume
- 8
- Issue
- 10
- Pages
- 1118
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2974147039
- Cited by
- 1,315
- References
- 266
- FWCI
- 44.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.